BD

BD Receives FDA 510(k) Clearance for EnCor EnCompass™ Breast Biopsy and Tissue Removal System

State-of-the-art, multi-modality breast biopsy system slated to be in the market in early 2026
BD Expands Peripheral Artery Disease Awareness Efforts with ‘Love Your Limbs’ Community Screening Initiative

BD Expands Peripheral Artery Disease Awareness Efforts with ‘Love Your Limbs’ Community Screening Initiative
BD to Initiate Real-World Patient Data Registry for the Rotarex™ Atherectomy System in Treatment of Peripheral Artery Disease

BD to Initiate Real-World Patient Data Registry for the Rotarex™ Atherectomy System in Treatment of Peripheral Artery Disease
BD Launches Landmark Cell Analyzer Featuring Breakthrough Spectral and Real-Time Cell Imaging Technologies

New BD FACSDiscover™ A8 Cell Analyzer Brings Leading-Edge Capabilities to Wider Range of Scientists across Academia and Biopharma
BD Resolves Previously Disclosed SEC Investigation

BD has reached an agreement with the U.S. SEC to resolve the previously disclosed investigation related to prior…
First of Its Kind HPV Self-Collection Study Launched to Improve Cervical Cancer Screening in Underserved Communities

First of Its Kind HPV Self-Collection Study Launched to Improve Cervical Cancer Screening in Underserved Communities
BD Completes Acquisition of Critical Care from Edwards Lifesciences

BD announced it has completed the acquisition of Edwards Lifesciences’ Critical Care product group, which will be renamed…
Edwards Lifesciences to Sell Critical Care to BD

Agreement strengthens Edwards’ strategy to advance structural heart innovation.
New Survey Reveals Patients Receive Too Many Needlesticks

Most Americans Unaware of Challenges from Common Hospital Procedures
BD Named Among Fortune’s Most Innovative Companies

BD Named Among Fortune’s Most Innovative Companies
BD, Techcyte Announce Strategic Collaboration to Offer AI-Based Digital Cervical Cytology System for Pap Testing

AI-Based Algorithm Aims to Enable Cytotechnologists and Pathologists to Efficiently Identify Evidence of Cervical Cancer and Precancerous Lesions
BD Helps Advance Health Equity for Women in Kenya through Critical Cancer Screening

Collaboration with Kenya Ministry of Health National Cancer Institute Aims to Expand Access to Diagnostics, Reduce Cervical Cancer…

Call to Action

Experience Seamless Style and Speed

Explore More

BD Receives FDA 510(k) Clearance for EnCor EnCompass™ Breast Biopsy and Tissue Removal System

BD Expands Peripheral Artery Disease Awareness Efforts with ‘Love Your Limbs’ Community Screening Initiative

BD to Initiate Real-World Patient Data Registry for the Rotarex™ Atherectomy System in Treatment of Peripheral Artery Disease

BD Launches Landmark Cell Analyzer Featuring Breakthrough Spectral and Real-Time Cell Imaging Technologies

BD Resolves Previously Disclosed SEC Investigation

First of Its Kind HPV Self-Collection Study Launched to Improve Cervical Cancer Screening in Underserved Communities

BD Completes Acquisition of Critical Care from Edwards Lifesciences

Edwards Lifesciences to Sell Critical Care to BD

New Survey Reveals Patients Receive Too Many Needlesticks

BD Named Among Fortune’s Most Innovative Companies

BD, Techcyte Announce Strategic Collaboration to Offer AI-Based Digital Cervical Cytology System for Pap Testing

BD Helps Advance Health Equity for Women in Kenya through Critical Cancer Screening

Call to Action

Post Category

Latest Posts

Social Links

SPECIAL THANKS TO OUR LEGACY & PLATINUM ELITE MEMBERS